4.00
3.90%
0.15
Dopo l'orario di chiusura:
3.91
-0.09
-2.25%
Precedente Chiudi:
$3.85
Aprire:
$3.85
Volume 24 ore:
27,911
Relative Volume:
0.22
Capitalizzazione di mercato:
$7.43M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.23%
1M Prestazione:
-11.70%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Quantum Biopharma Provides Corporate Update - Bluefield Daily Telegraph
Quantum Biopharma Provides Corporate Update - AccessWire
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Chronicle-Tribune
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - AccessWire
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Newswire
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Invesments and Kingswood US - StockTitan
Investor.News Prepares for the ArcStone-Kingswood Growth Summit 2024 - InvestorNews Inc.
Quantum BioPharma Closes Private Placement Offering - Invezz
Quantum BioPharma Closes Private Placement Offering - Newsfile
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know - MSN
Quantum BioPharma Ltd. announced that it has received CAD 0.000036 million in funding from Fortius Research and Trading Corporation, Xorax Family Trust - Marketscreener.com
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Quantum BioPharma to run multiple sclerosis progression study | 2024-09-09 | Investing News - Stockhouse Publishing
Quantum BioPharma partners for multiple sclerosis study - Investing.com
Quantum BioPharma partners for multiple sclerosis study - Investing.com India
S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Digital Journal
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease - PharmiWeb.com
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - AccessWire
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Nasdaq
The Globe and Mail - The Globe and Mail
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - StockTitan
ArcanaBio Secures Funding from BioInnovation Institute to Revolutionize Healthcare with new Ultra-Rapid Liquid Biopsy Technology - Via Ritzau
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - AccessWire
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - Newswire
Quantum BioPharma (QNTM) Experiences Pre-Market Boost - Stocks Telegraph
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
QNTM Stock: Exploring Quantum BioPharma Ltd.’s Growth - The InvestChronicle
AusBiotech cohosts Quantum Meets Health workshop - Biotech Dispatch
Understanding QNTM stock ratios for better investment decisions - US Post News
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 - Big News Network
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 - AccessWire
Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 - Yahoo Finance
August Wrap-up; New Stocks in biotech, transportation, tech, mining and defense - Investorideas.com newswire
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can "own NOW and what’s NEXT" - AccessWire
Celly Nutrition Launches unbuzzd Grab-and-Go Stick Packs on Amazon.com so You Can "Own Now and What's Next" - Newsfile
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Quantum Announces Reverse Stock Split - Yahoo Finance
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - AccessWire
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - Chronicle-Tribune
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - Nasdaq
InvestmentPitch Media Video Discusses FSD Pharma and Construction of its Heritage Museum and Flagship Dispensary at the Former Kraft Plant in OntarioVideo Available on Investmentpitch.com - Marketscreener.com
Qubit Pharmaceuticals nominated for "Best start-up" award at Prix Galien USA 2024 - Yahoo Finance
In the Green: Quantum BioPharma Ltd. (QNTM) Closes at 4.27, Up/Down 0.00 from Previous Day - The Dwinnex
Quantum BioPharma (XCNQ:QNTM) EPS (Basic) : C$-22.62 (TTM As of Mar. 2024) - GuruFocus.com
Quantum BioPharma (XCNQ:QNTM) Dividend Payout Ratio : 0.00 (As of Mar. 2024) - GuruFocus.com
Quantum BioPharma (XCNQ:QNTM) Dividends per Share : C$0.00 (TTM As of Mar. 2024) - GuruFocus.com
Quantum BioPharma (XCNQ:QNTM) EV-to-Revenue : (As of Aug. 18, 2024) - GuruFocus.com
Quantum BioPharma (XCNQ:QNTM) Short-Term Debt & Capital Lea - GuruFocus.com
Quantum BioPharma (STU:0K91) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com
QNTM (Quantum BioPharma) EV-to-Revenue : (As of Aug. 16, 2024) - GuruFocus.com
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Non sono disponibili dati finanziari per Quantum Biopharma Ltd (QNTM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):